Key points are not available for this paper at this time.
Herein we report a method for a stereoconvergent synthesis of trisubstituted alkenes in two steps from simple ketone starting materials. The key step is a nickel-catalyzed reduction of the corresponding enol tosylates that predominantly relies on a monophosphine ligand to direct the stereoconvergent formation of either the E- or Z-trisubstituted alkene products. Reaction optimization was accomplished using a data science workflow including monophosphine training set design, statistical modeling, and multiobjective Bayesian optimization. The optimization campaign significantly improved access to both the E- and Z-trisubstituted products in up to ∼90:10 diastereoselectivity and >90% yield. After identifying superior ligands using training set design, only 25 reactions were required for each objective (E- and Z-isomer formation) to converge on improved reaction parameters from a search space of ∼30,000 potential conditions using the EDBO+ platform. Additionally, a hierarchical machine learning model was developed to predict the stereoselectivity of untested monophosphine ligands to achieve a validation mean absolute error (MAE) of 7.1% selectivity (0.21 kcal/mol). Ultimately, we present a synergistic data science workflow leveraging the integration of training set design, statistical modeling, and Bayesian optimization, thereby expanding access to stereodefined trisubstituted alkenes.
Romer et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: